Published in Pathol Biol (Paris) on September 01, 1983
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol (1996) 1.24
Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas (1996) 1.23
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest (1993) 0.99
Elastin-elastase-atherosclerosis revisited. Atherosclerosis (1998) 0.97
Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol (1991) 0.89
[Presence of an anti-beta-lipoprotein autoantibody in a myeloma serum]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats. Lipids (1991) 0.88
Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit (1993) 0.88
International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev (1997) 0.87
Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler Thromb Vasc Biol (1997) 0.86
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
[Hyperlipidemia caused by auto-antibodies. A cause of atherosclerosis]. Presse Med (1967) 0.83
[Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity]. Nouv Rev Fr Hematol (1967) 0.83
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism (1992) 0.82
Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol (1997) 0.82
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol (1995) 0.82
Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med (1997) 0.82
Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes (1984) 0.81
Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta (1990) 0.81
Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients. Atherosclerosis (1995) 0.80
[A further case of hyperlipemia due to auto-antibodies. Its treatment with D-penicillamine]. Bull Mem Soc Med Hop Paris (1967) 0.80
Prevalence of dyslipidemia in liver transplant recipients. Transplantation (1992) 0.79
Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann Nutr Metab (1998) 0.79
Modification in the composition and metabolic properties of human low density and high density lipoproteins by different dietary fats. J Lipid Res (1984) 0.79
Effects of different dietary intake of essential fatty acids on C20:3 omega 6 and C20:4 omega 6 serum levels in human adults. Lipids (1985) 0.79
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery (1982) 0.78
The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia. Atherosclerosis (1985) 0.78
Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis. Ann Biol Clin (Paris) (1992) 0.78
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group. Br J Clin Pharmacol (1994) 0.78
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactions. Clin Physiol Biochem (1986) 0.78
Influence of environmental medium on fatty acid composition of human cells: leukocytes and fibroblasts. Lipids (1987) 0.78
Effects of three dietary fats on plasma lipids and lipoproteins in fasting and post-prandial humans after a short-term diet. Lipids (1980) 0.78
Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum Mol Genet (1994) 0.78
Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis (1999) 0.77
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients. Clin Chim Acta (1999) 0.77
Fluidity changes and chemical composition of lipoproteins in type IIa hyperlipoproteinemia. Biochim Biophys Acta (1990) 0.77
Dietary fats and lecithin-cholesterol acyltransferase activity in healthy humans. Ann Nutr Metab (1988) 0.77
Olive oil and the Mediterranean diet: implications for health in Europe. Br J Nurs (1997) 0.77
Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb (1993) 0.76
Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler Thromb Vasc Biol (1996) 0.76
In vitro preparation of elastin--triglyceride complexes. Fatty acid uptake and modification of the susceptibility to elastase action. Atherosclerosis (1980) 0.76
Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia. Ann Nutr Metab (1991) 0.76
Influence of diet on the plasma levels and distribution of ApoA-I-containing lipoprotein particles. Prog Lipid Res (1991) 0.76
Cultured fibroblast interactions with LDL and HDL from healthy subjects on various dietary fats. Adv Exp Med Biol (1987) 0.75
Study of free and esterified cholesterol in skin in atherogenic hyperlipidemias. Pathol Biol (Paris) (1981) 0.75
[Women and ischemic cardiopathy]. Rev Clin Esp (1989) 0.75
[Effects of ileal bypass and porto-caval anastomosis on blood and arterial wall lipids in normal and hyperlipidemic rats]. Med Chir Dig (1978) 0.75
[Cutaneous cholesterol in coronary disease in man. Comparison of 2 technics of extraction]. Paroi Arterielle (1977) 0.75
[Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns]. Ann Med Interne (Paris) (1988) 0.75
Influence of the fatty acid composition of high-density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochim Biophys Acta (1986) 0.75
[A case of Legionnaires' disease with pericardial involvement]. Presse Med (1984) 0.75
[Type V hyperlipemia. 54 cases (author's transl)]. Nouv Presse Med (1979) 0.75
[Leg aneurysm complicating bacterial endocarditis. 2 cases]. Presse Med (1983) 0.75
Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia. Atherosclerosis (1986) 0.75
[Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)]. Sem Hop (1980) 0.75
[Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)]. Pathol Biol (Paris) (1979) 0.75
Experimental pharmacological study of moroxybrate, a hypolipidaemic, antithrombotic, antiatheromatous agent. J Pharm Pharmacol (1987) 0.75
[Atherosclerosis: basic mechanisms]. Sem Hop (1983) 0.75
Application of two multi-dimensional analytical methods to histological study of the aorta in dietary atherosclerosis of the rabbit. Artery (1980) 0.75
[Dietary fats, lipoproteins and atherogenesis]. Pathol Biol (Paris) (1985) 0.75
Tertatolol does not affect biochemical markers of atherosclerosis in normo- and hyperlipidemic hypertensive patients. Am J Nephrol (1986) 0.75
[The role of hypolipidaemic agents in the fight against atherosclerosis (author's transl)]. Nouv Presse Med (1980) 0.75
[Type II familial hyperlipoproteinaemia : value of plasma exchange treatment (author's transl)]. Ann Med Interne (Paris) (1982) 0.75
[Plasma binding and pharmacokinetics of drugs]. Rev Med Interne (1982) 0.75
[Atheromatous lesions. Description of lesions and pathogenic mechanisms]. Rev Prat (1979) 0.75
[Detection and treatment of lipid disorders]. Rev Clin Esp (1988) 0.75
Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia. Adv Exp Med Biol (1988) 0.75
[Resins in the treatment of hypercholesterolemia]. Med Chir Dig (1978) 0.75
[Beta-adrenergic inhibitors and atherogenic risk]. Therapie (1986) 0.75
Effect of lipoproteins on the elastase activity expressed by human skin fibroblasts in culture. Cell Biol Int Rep (1988) 0.75
Cholesterol efflux from cultured skin fibroblasts in 12 patients clinically heterozygous for familial hypercholesterolemia. Clin Chim Acta (1986) 0.75
[Pulmonary interstitial electron dense deposits in lupus erythematosus. Interest of the transbronchial biopsy (author's transl)]. Ann Med Interne (Paris) (1981) 0.75
Effects of several alimentary fats on serum lipids during long-term stabilized diets. Ann Nutr Metab (1984) 0.75
Lipoprotein particle analysis comparing simvastatin and fenofibrate. Atherosclerosis (1991) 0.75
Effect on rat blood and aorta lipids of three edible oils (arachid, sunflower and primor) with low saturated fatty acid content. Nutr Metab (1978) 0.75
[Effects of tertatolol on atherogenicity indices in normo- or dis-lipemic hypertensive patients]. Ann Med Interne (Paris) (1987) 0.75
Seasonal variations of serum lipids and apoproteins. Ann Nutr Metab (1988) 0.75
[Trial of onager oil in the treatment of schizophrenia in connection with the prostaglandin deficiency hypothesis]. Encephale (1984) 0.75
[Metabolism of lipoproteins: role of specific receptors]. Journ Annu Diabetol Hotel Dieu (1987) 0.75
[Nicotine gum and lipid profile]. Pathol Biol (Paris) (1989) 0.75
[Atheromatous lesions. Complications]. Rev Prat (1979) 0.75
[Children and dyslipemia]. Rev Clin Esp (1990) 0.75
[Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia]. Presse Med (1988) 0.75
[Non-pharmacologic treatment of hyperlipemia: diet and exercise]. Rev Clin Esp (1990) 0.75
Comparative effects of canbra oil and butter on lipdemia, vitamin A tolerance and thrombosis factors in man. J Med (1978) 0.75
[Standard values for serum esterified fatty acids in adult women in good health]. Ann Nutr Metab (1987) 0.75
[Free and esterified cholesterol of the skin in atherogenic hyperlipidemias]. Paroi Arterielle (1981) 0.75
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia. Eur J Clin Pharmacol (1989) 0.75
[Effects of several dietary oils on blood and arterial lipids of rats fed an equilibrated normolipid diet for one year]. Ann Nutr Aliment (1977) 0.75
Effects of several lipid-lowering drugs on skin total and esterified cholesterol. Monogr Atheroscler (1986) 0.75
Serum and aortic lipids of rats fed long-term equilibrate diets containing various alimentary fats. Adv Exp Med Biol (1977) 0.75
[When should hypercholesterolemia patients be diagnosed and treated?]. Rev Prat (1989) 0.75
[Role of non-pharmacological treatment in the prevention of atherosclerosis]. Presse Med (1986) 0.75
[Determination of lipoprotein Lp(a). A semi-automatic immuno-turbidimetric method]. Pathol Biol (Paris) (1991) 0.75
[Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)]. Nouv Presse Med (1980) 0.75
[Prevention of coronary disease: general policy of the European Atherosclerosis Society]. Rev Prat (1988) 0.75
[HDL cholesterol profile in 1988]. Rev Clin Esp (1989) 0.75
Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia. Eur Heart J (1990) 0.75